Skip to main content
Premium Trial:

Request an Annual Quote

NanoInk Raises $65M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced a $65 million financing led by Lurie Investments.

The Skokie, Ill., nanotechnology development and applications firm said in a statement that the money will be used to convert outstanding debt to equity and to expand its commercial activities. NanoInk markets and sells nine nanotechnology products across its different divisions.

The company has five divisions, including the Nano BioDiscovery division, created in 2008 to apply its technology to the life sciences market. The division supplies instruments, assay kits, and contract services for nanoscale protein detection using the company's Dip Pen Nanolithography nanofabrication technology.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.